Diabetes I: Insulins.

BMJ
doi 10.1136/bmj.286.6376.1502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Future of Biosimilar Insulins

Diabetes Spectrum
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Clinical Benefits of Switching Type 2 Diabetes Patients From Human Insulins to Insulin Analogs

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2013English

New Insulins, Biosimilars, and Insulin Therapy

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Effectiveness of Insulin Analogs Compared With Human Insulins in Pregnant Women With Diabetes Mellitus: Systematic Review and Meta-Analysis

Revista Brasileira de Ginecologia e Obstetricia
GynecologyObstetrics
2019English

Duration of the Action of Different Insulins

BMJ
1952English

Høy Dødelighet Ved Diabetes I Mexico

Tidsskrift for den Norske Laegeforening
Medicine
2017English

Detaljert Håndbok I Endokrinologi Og Diabetes

Tidsskrift for den Norske Laegeforening
Medicine
2011English

Protamine and Protamine-Insulins Exacerbate the Vascular Response to Injury.

Journal of Clinical Investigation
Medicine
1993English

The Conformation of Insulin-Like Growth Factors: Relationships With Insulins

Journal of Cell Science
Cell Biology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy